Chennai Urology And Robotics Institute Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 23-10-2024
- Paid Up Capital ₹ 1.00 M
as on 23-10-2024
- Company Age 11 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 51.32 Cr
as on 23-10-2024
- Revenue -14.19%
(FY 2023)
- Profit -34.09%
(FY 2023)
- Ebitda -25.90%
(FY 2023)
- Net Worth 16.95%
(FY 2023)
- Total Assets -7.00%
(FY 2023)
About Chennai Urology And Robotics Institute
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹51.32 Cr.
Shanmuganathan Rajasababathy, Sivaraman Ananthakrishnan, Gayathri Ananthakrishnan, and One other member serve as directors at the Company.
- CIN/LLPIN
U85190TN2013PTC093647
- Company No.
093647
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Nov 2013
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Kanchipuram, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Chennai Urology And Robotics Institute?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sivaraman Ananthakrishnan  | Director | 12-Nov-2013 | Current |
| Shanmuganathan Rajasababathy | Director | 28-Dec-2016 | Current |
| Gayathri Ananthakrishnan | Director | 12-Nov-2013 | Current |
| Puliangudi Balakrishnan | Director | 12-Jul-2017 | Current |
Financial Performance of Chennai Urology And Robotics Institute.
Chennai Urology And Robotics Institute Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 14.19% decrease. The company also saw a substantial fall in profitability, with a 34.09% decrease in profit. The company's net worth Soared by an impressive increase of 16.95%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Chennai Urology And Robotics Institute?
In 2023, Chennai Urology And Robotics Institute had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ganga Medical Centre And Hospitals Private LimitedActive 30 years 9 daysShanmuganathan Rajasababathy is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 05 Oct 2023 | ₹4.00 M | Open |
Others Creation Date: 24 Nov 2021 | ₹3.64 Cr | Open |
Others Creation Date: 14 Sep 2020 | ₹7.28 Cr | Open |
How Many Employees Work at Chennai Urology And Robotics Institute?
Chennai Urology And Robotics Institute has a workforce of 107 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Chennai Urology And Robotics Institute, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chennai Urology And Robotics Institute's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
